HER2 – State of the Art Jubilee Symposium

09.00 Registration and coffee
10.00 Welcome and Introduction, Professor Jonas Bergh and Professor Mårten Fernö
10.10 HER2 the true story, Professor Daniel F. Hayes
10.55 Cardiac safety, Ass. Professor Elham Hedayati
11.30 Molecular diagnostics from IHC to genome profile (focus on biology), Professor Åke Borg
12.05 Clinical diagnosis of HER2 positive disease (focus on clinical application), Ass. Professor Johan Hartmann
12.40 Lunch
13.40 Shorter duration, longer duration, double blockade, antibody drug conjugate, which treatment to which patient?, Professor Sandra Swain
14.25 PREDIX data in context, Ass. Professor Thomas Hatschek
15.00 Coffee
15.30 Regional and country based uptake of important drug innovation with focus on HER directed drugs, Ass. Professor Nils Wilking
16.05 Personal reflections on 20 years development of anti-HER 2 therapies, Professor Per Eystein Lønning
16.25 Discussion and closure
MD PhD Ana Bosch Campos and Ass. Professor Theodoros Foukakis

Registration no later than May 20.
For more information and registration, click here